Pluvicto and Acute kidney failure - a phase IV clinical study of FDA data

Summary:

Acute kidney failure is reported as a side effect among people who take Pluvicto (lutetium lu-177 vipivotide tetraxetan), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Fentanyl, and have Prostate cancer.

The phase IV clinical study analyzes which people have Acute kidney failure when taking Pluvicto. It is created by eHealthMe based on reports of 5,722 people who have side effects when taking Pluvicto from the FDA, and is updated regularly.

What is Pluvicto?

Pluvicto has active ingredients of lutetium lu-177 vipivotide tetraxetan. eHealthMe is studying from 5,722 Pluvicto users. Check the latest studies of Pluvicto.

What is Acute kidney failure?

Acute kidney failure is found to be associated with 2,836 drugs and 4,499 conditions by eHealthMe. Check the latest studies of Acute kidney failure.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 08, 2026

5,722 people reported to have side effects when taking Pluvicto.
Among them, 16 people (0.28%) have Acute kidney failure.

Could Pluvicto cause Acute kidney failure?

Among these 16 people:

How long have people been on Pluvicto when they have Acute kidney failure? *

What is the gender of people who have Acute kidney failure when taking Pluvicto? *

female: 0.0 %
male: 100 %

What is the age of people who have Acute kidney failure when taking Pluvicto? *

What are other drugs people take besides Pluvicto? *

Oxycodone Hydrochloride: 2 people, 12.50%
Fentanyl: 2 people, 12.50%
Zytiga: 1 person, 6.25%
Xgeva: 1 person, 6.25%
Prednisone: 1 person, 6.25%
Lupron: 1 person, 6.25%
Furosemide: 1 person, 6.25%
Erleada: 1 person, 6.25%
Eliquis: 1 person, 6.25%
Docetaxel: 1 person, 6.25%

What are other side effects people have besides Acute kidney failure? *

Anaemia (lack of blood): 6 people, 37.50%
General Physical Health Deterioration (weak health status): 3 people, 18.75%
Renal Impairment (severely reduced kidney function): 3 people, 18.75%
Thrombocytopenia (decrease of platelets in blood): 3 people, 18.75%
Leukopenia (less number of white blood cells in blood): 2 people, 12.50%
Urinary Retention (the inability to completely or partially empty the bladder): 2 people, 12.50%
Rectal Haemorrhage (bleeding from anus): 2 people, 12.50%
Prostate Cancer: 1 person, 6.25%
Haemoglobin Decreased: 1 person, 6.25%
Blood Creatinine Increased: 1 person, 6.25%

What are the existing conditions these people have? *

Prostate Cancer: 6 people, 37.50%
Metastases To Bone (cancer spreads to bone): 1 person, 6.25%
High Blood Pressure: 1 person, 6.25%
Dyslipidaemia (abnormal amount of lipids): 1 person, 6.25%
Arrhythmias (irregular heartbeat): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Pluvicto and have Acute kidney failure?

- Check whether Acute kidney failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pluvicto:

Pluvicto (5,722 reports)

Acute kidney failure treatments and more:

Acute kidney failure (259,717 reports)

How severe was Acute kidney failure and when was it recovered:

Acute kidney failure in Pluvicto

Expand to all the drugs that have ingredients of lutetium lu-177 vipivotide tetraxetan:

Acute kidney failure and drugs with ingredients of lutetium lu-177 vipivotide tetraxetan

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pluvicto:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Acute kidney failure:

Acute kidney failure (2,836 drugs)

Browse all the conditions that are associated with Acute kidney failure:

Acute kidney failure (4,499 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lutetium lu-177 vipivotide tetraxetan (the active ingredients of Pluvicto) and Pluvicto (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.